Procurement of APIs, intermediates, excipients, and other pharma raw materials in a secured manner is very important for global pharma corporations. Supplier selection for manufacturing, procurement, trading, and distribution operations is not just about making comparisons based on price but rather includes quality, regulation compliance, production capability, documentation, logistics, and supply sustainability.
The trend toward globalization of pharmaceutical supply chains has seen buyers looking for API suppliers globally, region-specific manufacturers, and dedicated pharma raw material suppliers.
This guide provides information about global sourcing regions, considerations for buyers, and digital business-to-business platforms for supplier search.
The providers of APIs produce or distribute those active pharmaceutical ingredients which make the medicine have its therapeutic effect. Pharma raw material suppliers may also provide:
According to the model of business, the supplier may be either the original manufacturer, contract manufacturer, trader, distributor, or exporter.
It is vital for the procurement section to identify the supplier because the processes in regard to documentation, manufacturing process, cost, lead time, and personal interaction might differ from one supplier to another.
The raw materials used in pharmaceuticals come from various regions of manufacturing and not from one country only. India, China, Europe, America, Japan, and others in Asia all have their unique manufacturing capabilities in different products.
|
Region |
Common sourcing strengths |
|
India |
APIs, generic-drug raw materials, intermediates, specialty chemicals, nutraceutical ingredients |
|
China |
APIs, intermediates, chemicals, starting materials, large-scale chemical manufacturing |
|
European Union |
Specialty APIs, high-value intermediates, excipients, regulated pharmaceutical manufacturing |
|
United States |
Specialized APIs, biotechnology-related materials, high-value pharmaceutical ingredients |
|
Japan |
High-purity pharmaceutical ingredients, specialty chemicals, advanced manufacturing |
|
South Korea |
APIs, intermediates, specialty chemicals and biopharmaceutical materials |
|
Southeast Asia |
Emerging pharmaceutical and chemical manufacturing and regional distribution |
These are broad sourcing patterns, not a substitute for evaluating individual manufacturers.
A well-defined manufacturing network for the production of APIs, intermediates, formulations, specialty chemicals, and related raw materials has been established in India.
The Indian manufacturers are important to buyers searching for:
For international buyers, however, country of origin alone does not establish supplier suitability. The individual manufacturer's regulatory history, quality system, product specifications, certifications, and export experience should be assessed.
China is a country that has a great chemical manufacturing industry and is a significant provider of APIs, intermediates, starting materials, and specialty chemicals.
This wide-ranging manufacturing system will give the buyers access to many suppliers in different sizes of productions.
While buying from China, buyers should take note of:
A low quoted price should not be evaluated independently from quality and supply-chain requirements.
Markets in Europe for pharmaceutical production are especially important for drugs that need advanced production technologies, complex chemistry, or rigorous regulation.
European suppliers may operate across:
When procurement is done from Europe, then the buyers need to analyze the relevant regulation system, manufacturing licensing or registration, and quality-related issues.
Other nations outside of India, China, Europe, and the USA that have developed pharmaceuticals and chemical manufacturing abilities include Japan and South Korea.
Alternative manufacturing regions might also prove to be alternative sourcing locations, especially for regional buyers and firms looking for alternatives to diversify their sources.
The best geography for sourcing varies based on the product. An API manufacturer with suitable regulatory documentation and manufacturing capabilities may be more relevant than a supplier located in a traditionally recognized pharmaceutical hub.
Finding a supplier is only the first stage. Procurement teams should build a structured qualification process.
Determine whether the company is:
Ask for the manufacturing site's details when purchasing directly from a manufacturer.
Based on the product and market into which the product is being sold, documentation may include:
Documentation requirements vary by API, market, and intended application.
Before requesting commercial quotations, define the technical requirements.
Important parameters may include:
Using a CAS number search or standardized chemical identifier can also reduce confusion between similarly named substances.
A supplier may be suitable for a laboratory-scale requirement but unable to support commercial quantities.
Ask about:
Pharmaceutical procurement requires more than one successful shipment.
Evaluate the supplier's:
For critical APIs, qualifying alternative suppliers can reduce dependence on a single source.
|
Evaluation area |
What buyers should verify |
|
Company |
Legal identity and business type |
|
Manufacturing |
Actual manufacturing location |
|
Quality |
GMP and quality-system documentation |
|
Product |
Specifications and grade |
|
Regulatory |
Applicable registrations and documentation |
|
Capacity |
Batch size and production capability |
|
Commercial |
MOQ, price and payment terms |
|
Logistics |
Lead time, packaging and shipping |
|
Reliability |
Delivery history and responsiveness |
|
Compliance |
Destination-market requirements |
Historically, sourcing for the pharmaceutical industry has been based on networking, tradeshows, referrals, distributors, and individual suppliers. All of the above are valuable, yet they may limit supplier visibility.
A B2B digital sourcing platform can structure the process of supplier discovery by enabling the buyer to find products based on category, supplier profile, market, and procurement requirements.
When a company is putting together its list of global suppliers for API sourcing, supplier discovery can help identify suppliers prior to qualification.
However, supplier listings should be treated as a starting point—not as automatic evidence of regulatory or quality compliance.
ChemDmart is a business-to-business (B2B) pharma and chemicals marketplace based on supplier identification, procurement, RFQ, and global sourcing.
For the pharmaceutical industry, procurement professionals, traders, distributors, exporters, importers, CROs/CDMOs, and SMEs, it may be easier to identify possible suppliers of APIs, pharmaceutical raw materials, chemicals, and nutraceuticals in a centralized sourcing system.
The process should be:
Search → Shortlist → Request Information → Compare → Qualify → Purchase
The critical point here is that supplier discovery and supplier qualification are two different processes. It is essential to independently validate the information and documentation for each particular product in the market.
There is no universally applicable supplier geography for all pharmaceutical buyers.
The appropriate source depends on:
In case of strategic APIs, dual sourcing or multi sourcing could be another option for the purchasing team to look into. Maintaining alternative sources could minimize the disruption that the supplier may face because of certain issues.
The API and pharma raw material supplier markets worldwide span India, China, Europe, the USA, Japan, South Korea, and many more manufacturing markets around the world. All these markets have unique strengths, and supplier selection should be driven by product needs and not purely geographic considerations.
For procurement professionals, the best strategy is the combination of global discovery and qualification of suppliers in terms of quality, regulatory documentation, manufacturing capacity, prices, logistics, and supply.
Suppliers such as ChemDmart can help procurement teams achieve the goal of global discovery and sourcing of suppliers in a structured manner.